Granules India Ltd

Granules India Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Granules India Ltd

₹ 421 0.83%
26 Apr 12:42 p.m.
granulesindia.com BSE: 532482 NSE : GRANULES
About

Granules India Ltd and its subsidiaries are primarily involved in the manufacturing and selling of Active Pharma Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages.[1]

Key Points

Business Segments FY23

Website BSE NSE
  • Market Cap ₹ 10,213 Cr.
  • Current Price ₹ 421
  • High / Low ₹ 480 / 272
  • Stock P/E 25.8
  • Book Value ₹ 122
  • Dividend Yield 0.36 %
  • ROCE 19.4 %
  • ROE 19.1 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company's median sales growth is 19.2% of last 10 years

Cons

  • Company might be capitalizing the interest cost

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
845 799 850 888 997 1,030 1,020 1,151 1,146 1,196 986 1,189 1,156
633 597 648 737 823 837 808 908 915 967 849 977 905
Operating Profit 212 202 201 151 174 193 212 243 231 228 137 213 250
OPM % 25% 25% 24% 17% 17% 19% 21% 21% 20% 19% 14% 18% 22%
16 3 8 4 5 4 5 5 1 3 0 2 1
Interest 7 7 7 5 5 6 7 13 17 19 22 26 29
Depreciation 37 44 39 40 39 40 43 44 48 49 49 53 52
Profit before tax 184 154 163 110 135 150 166 190 167 164 65 136 170
Tax % 20% 17% 26% 27% 25% 26% 23% 24% 26% 27% 27% 25% 26%
147 128 120 81 101 111 128 145 124 120 48 102 126
EPS in Rs 5.93 5.15 4.85 3.26 4.07 4.48 5.14 5.84 5.14 4.94 1.98 4.21 5.18
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
654 761 1,084 1,292 1,357 1,411 1,685 2,279 2,599 3,238 3,765 4,512 4,526
575 676 925 1,082 1,081 1,112 1,406 1,895 2,073 2,382 3,038 3,597 3,698
Operating Profit 79 86 159 210 276 299 278 384 526 856 727 915 828
OPM % 12% 11% 15% 16% 20% 21% 17% 17% 20% 26% 19% 20% 18%
1 1 4 3 5 35 27 75 90 26 13 12 6
Interest 17 18 20 32 37 32 33 28 27 26 23 56 96
Depreciation 21 23 30 53 58 72 76 105 137 151 159 184 203
Profit before tax 43 46 112 128 186 230 196 326 451 704 558 687 536
Tax % 30% 30% 33% 29% 33% 28% 32% 27% 26% 22% 26% 25%
30 33 75 91 123 165 133 236 335 549 413 517 395
EPS in Rs 1.49 1.62 3.71 4.45 5.68 7.19 5.22 9.30 13.19 22.18 16.64 21.34 16.31
Dividend Payout % 13% 12% 9% 11% 11% 13% 19% 11% 8% 7% 9% 7%
Compounded Sales Growth
10 Years: 19%
5 Years: 22%
3 Years: 20%
TTM: 4%
Compounded Profit Growth
10 Years: 32%
5 Years: 31%
3 Years: 18%
TTM: -22%
Stock Price CAGR
10 Years: 28%
5 Years: 30%
3 Years: 8%
1 Year: 38%
Return on Equity
10 Years: 20%
5 Years: 20%
3 Years: 21%
Last Year: 19%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 20 20 20 20 22 23 25 25 25 25 25 24 24
Reserves 225 255 336 411 640 881 1,279 1,504 1,818 2,149 2,562 2,811 2,943
204 270 442 482 641 656 978 991 892 849 1,106 1,136 1,380
123 137 194 289 260 319 388 458 487 690 819 932 918
Total Liabilities 571 683 992 1,203 1,563 1,879 2,670 2,979 3,223 3,713 4,512 4,903 5,265
250 263 482 617 560 644 777 944 1,204 1,332 1,541 1,911 2,063
CWIP 29 109 125 62 77 267 515 496 294 239 356 239 219
Investments 0 10 0 0 70 108 157 210 19 19 20 21 21
291 301 385 524 856 859 1,222 1,328 1,706 2,123 2,594 2,732 2,961
Total Assets 571 683 992 1,203 1,563 1,879 2,670 2,979 3,223 3,713 4,512 4,903 5,265

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
26 91 108 150 151 188 -1 262 476 432 332 739
-54 -128 -255 -146 -162 -326 -462 -270 -160 -277 -379 -192
49 46 147 19 86 56 529 -17 -213 -299 190 -440
Net Cash Flow 20 10 0 24 75 -82 66 -25 103 -144 143 107

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 53 34 37 39 101 108 136 108 93 86 90 77
Inventory Days 97 107 99 110 128 145 114 112 125 205 190 182
Days Payable 67 72 77 92 91 116 112 94 102 142 124 124
Cash Conversion Cycle 83 69 59 57 138 137 138 126 116 150 156 135
Working Capital Days 65 56 48 41 115 120 156 120 116 109 119 102
ROCE % 15% 13% 20% 19% 20% 18% 12% 15% 17% 25% 17% 19%

Shareholding Pattern

Numbers in percentages

Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
42.04% 42.04% 41.98% 41.98% 41.98% 41.93% 42.02% 42.02% 42.02% 41.97% 41.97% 41.96%
18.35% 21.18% 21.38% 23.19% 23.13% 22.35% 23.66% 23.90% 21.35% 21.48% 18.78% 19.57%
2.86% 2.77% 4.34% 3.98% 3.03% 4.32% 4.75% 5.03% 6.68% 7.06% 10.16% 10.70%
36.76% 34.01% 32.30% 30.85% 31.85% 31.40% 29.56% 29.05% 29.95% 29.51% 29.10% 27.77%
No. of Shareholders 2,61,1652,39,5202,16,3852,10,7852,14,5392,16,0551,90,8941,87,7772,01,0542,07,0551,90,6911,82,142

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls